A portable device designed for personal use allows individuals to monitor their blood’s clotting ability, a crucial health metric often referred to as Prothrombin Time/International Normalized Ratio (PT/INR). This measurement helps determine the effectiveness of anticoagulant medications, commonly prescribed to prevent dangerous blood clots. Regular self-testing can empower patients to manage their therapy more effectively, leading to improved health outcomes.
Maintaining the correct anticoagulation levels is vital for individuals at risk of stroke or other thromboembolic events. Historically, frequent visits to a healthcare facility were necessary for INR monitoring. Home testing offers greater convenience and flexibility, reducing the burden on both patients and the healthcare system. Regular monitoring allows for timely dosage adjustments, minimizing the risk of complications associated with both over- and under-coagulation. This empowers patients to take an active role in their health management, potentially leading to improved quality of life.